AUC for ranolazin var uforandret hos patienter med let nedsat leverfunktion, men steg 1, 8 gange hos patienter med moderat nedsat leverfunktion.
Ranolazine AUC was unaffected in patients with mild hepatic impairment but increased 1.8-fold in patients with moderate impairment.